Article
Storytelling, Awareness, and the Race Against Time in Duchenne Muscular Dystrophy
A conversation with advocate Thomas Bartlett on why storytelling and public awareness, as much as science, drive funding, policy, and access in Duchenne.
All articles and blog posts tagged #rare-disease.
A conversation with advocate Thomas Bartlett on why storytelling and public awareness, as much as science, drive funding, policy, and access in Duchenne.
Health information about Duchenne can be misleading, exaggerated, or incomplete. Practical media literacy questions for families.
Regulatory news about DMD therapies can be confusing. A practical guide to reading FDA, EMA, and post-marketing safety updates carefully.
Health technology assessment shapes which rare disease therapies are funded, and how. A primer for families and advocates.
Accelerated approval pathways are central to modern rare disease therapy. They are useful, controversial, and often misunderstood.